These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG. Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454 [Abstract] [Full Text] [Related]
6. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS. Tuononen K, Mäki-Nevala S, Sarhadi VK, Wirtanen A, Rönty M, Salmenkivi K, Andrews JM, Telaranta-Keerie AI, Hannula S, Lagström S, Ellonen P, Knuuttila A, Knuutila S. Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162 [Abstract] [Full Text] [Related]
9. High resolution melting analysis for epidermal growth factor receptor mutations in formalin-fixed paraffin-embedded tissue and plasma free DNA from non-small cell lung cancer patients. Jing CW, Wang Z, Cao HX, Ma R, Wu JZ. Asian Pac J Cancer Prev; 2014 Jan; 14(11):6619-23. PubMed ID: 24377577 [Abstract] [Full Text] [Related]
10. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies. Do H, Dobrovic A. Mol Cancer; 2009 Oct 08; 8():82. PubMed ID: 19811662 [Abstract] [Full Text] [Related]
15. Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue. Miyamae Y, Shimizu K, Mitani Y, Araki T, Kawai Y, Baba M, Kakegawa S, Sugano M, Kaira K, Lezhava A, Hayashizaki Y, Yamamoto K, Takeyoshi I. J Mol Diagn; 2010 Mar 08; 12(2):257-64. PubMed ID: 20093389 [Abstract] [Full Text] [Related]